Scoop
AI NativeThe economic layer for human communities.
Est 2025|Raised $500K
The economic layer for human communities.
Published Jul 21, 2026
No market share or customer count for Scoop was found. Startup accelerator materials indicate a small team at the time of listing.
| Starting Price | Not public (demo-led) | Not public (enterprise quote) | Published per-user/year pricing available from the vendor |
| Best For | Preclinical IND narrative drafting and ongoing maintenance with sentence-level traceability | Large/mid biopharma needing end-to-end submissions content management and assembly | Smaller biopharma/consultancies needing cloud eCTD publishing/validation |
| Key Strength | Continuous reconciliation of narratives and linkage to source documents | Mature enterprise platform with content/workflow/data model for submissions lifecycle | Clear eCTD publishing/validation focus with published starting price |
| Key Weakness | Early-stage product with limited public proof points and limited publicly available security/compliance detail | Complexity, implementation time, and enterprise cost | Focused on publishing/validation; less emphasis on narrative drafting and maintenance |
—
Scoop vs end-to-end RIM suites (Veeva / ArisGlobal):
Scoop vs publishing/compilation tools (LORENZ / EXTEDO / Freyr):